BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 27.95
-0.45 (-1.58%)
At close: Feb 11, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.78 billion as of February 11, 2026. Its market cap has decreased by -2.47% in one year.
Market Cap
3.78B
Enterprise Value
2.60B
Revenue
3.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.95
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.78B, an increase of 114.23%. That is a compound annual growth rate of 23.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.78B | -4.54% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 4.55B |
| Medigen Biotechnology | 4.40B |
| ACRO Biomedical | 4.27B |
| Energenesis Biomedical CO.,LTD. | 4.15B |
| Formosa Pharmaceuticals | 4.10B |
| Genovate Biotechnology | 3.64B |
| Intech Biopharm | 3.57B |
| Syngen Biotech | 3.47B |